MUMBAI: Industries of Ayurveda, Siddha and Unani (ASU) have firmly opposed the provisions which are enlisted in the draft rule 161 that is issued by the Department of Ayush. As per the provision, it requires all the ASU manufacturers to provide extra details on the labels of Indian Systems of Medicine (ISM) which is covered under the patent or proprietary of ASU therapies.
The entire idea of approving this provision is not pointless at all. The main reason is to lead redundant uncertainty within the industry. In the joint meeting held on June 13, the industry has expressed all its related concerns to the department.
“It is not possible for us to incorporate both scientific as well as official name on a single label along with all the ingredients which can range from 60 to 90 at times based on the products. Most importantly, to incorporate all of them in a single label we will be forced to reduce the font size which will further lead to violation of weight and measurement act.” said Chandrakanth Bhanushali, general secretary, Ayurvedic Drug Manufacturer’s Association.